Human Gene Sequencing Markets: Strategies and Trends, Forecasts by Application, Technology, Workflow, Product and Country with Executive and Consultant Guides 2023 to 2027
“70,000 tests are available already with more on the way. Human gene sequencing is taking off. A crowded growing global market with complicated packaging and pricing is emerging with unlimited growth opportunities……”
Publication date: September 2023
Page count: 748
- Will all newborns receive genetic testing at birth?
- Which segments are growing fastest?
- Where are the opportunities now that sequencing has gone mainstream?
The plummeting costs for genome sequencing is creating a gold rush. New consumers, new technologies, new market niches. Reminiscent of the birth of the internet industry; a wide range of well funded players are racing for market share on a global stage. This report forecasts the market size out to 2027 and includes detailed breakouts for 14 countries and 5 regions.
Tumor Cell Sequencing? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities, and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.
All report data is available in Excel format on request.
Our research makes you the expert in your organization. Get our research team working for you by ordering this comprehensive report. Check all your licensing options but your order is available as a credit if you wish to upgrade. We wrote this report and we are ready, by phone or email, to help you use it. As always, assistance and additional specific data is provided without additional charges.
All report data is available in Excel format on request with a corporate license purchase.
Make investment decisions and valuations with confidence using the latest data.
ABOUT THE LEAD AUTHOR
Mr. Greg Powell, B.SC., M.B.A is an experienced business and clinical professional. He is co-author of the paper "The Radioimmunoassay of Angiotensinogen by Antibody Trapping." He has worked in laboratory testing and management for over 20 years. Mr. Powell’s education includes:
- B.Sc. (Chemistry) University of BC
- M.B.A. (Finance and Policy) University of BC
- Market Research Seminar - Burke Institute
- Finance for Senior Executives - Harvard Business School